The British drug giant confirmed on Monday that the British drug giant from AstraZeneca has received permission to use it as a booster or third strike in the European Union.
This was announced on Thursday by the European Medicines Agency.
“The AstraZeneca Covid-19 vaccine, Vaxzevria, has received EU approval from the EMA as a third dose booster in adults, ”the company said in a statement.
“Healthcare professionals can now use Vaxzevria as a third-dose booster in patients who have previously been assigned a primary vaccine schedule schedule of either Vaxzevria or EU-approved Covid-19 mRNA. vaccine».
The EMA concluded that there is “significant amount of evidence demonstrating an enhanced immune response after the third booster vaseuria,” he added.
AstraZeneca quickly deployed a successful strike on Covid-19 along with Oxford University during the pandemic.
Last month, the group announced that Vaxzevria sales quadrupled to $ 1.15 billion in the first quarter, despite a 40 percent decline in Europe, where the pandemic was halted by vaccinations.
But AstraZeneca also warned in April that revenues from Covid, including Vaxzevria, would decline this year as the health crisis recedes.
© 2022 AFP
Citation: AstraZeneca Covid jab has received EU approval as a booster: the firm (2022, 23 May) received on 23 May 2022 from https://medicalxpress.com/news/2022-05-astrazeneca-covid-jab-eu-booster .html
This document is subject to copyright. With the exception of any fair transactions for the purpose of private study or research, no part may be reproduced without written permission. The content is provided for informational purposes only.